Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future

Constitutively activated prosurvival pathways render cancer cells addicted to their effects. Consequently they turn out to be the Achilles' heels whose inhibition can be exploited in anticancer therapy. Primary effusion lymphomas (PELs) are very aggressive non-Hodgkin's B cell lymphomas, w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biomed Res Int
Auteurs principaux: Granato, Marisa, Santarelli, Roberta, Gonnella, Roberta, Farina, Antonella, Trivedi, Pankaj, Faggioni, Alberto, Cirone, Mara
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2015
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4324489/
https://ncbi.nlm.nih.gov/pubmed/25695042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/104912
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires